MENLO PARK, Calif., and NEW YORK – Drawbridge Health and Thorne Research have announced a strategic collaboration to develop solutions for improving the blood collection experience for health and wellness customers. Under the terms of the agreement, Thorne Research will receive exclusive rights to distribute and commercialize future Drawbridge Health products within the U.S. health and wellness industry, and Thorne Research has agreed to a multimillion-dollar investment into Drawbridge Health. Paul Jacobson, CEO of Thorne Research, has also joined the Drawbridge board of directors. “We are extremely excited about bringing this game-changing blood collection technology to our customers,” said Jacobson in a statement. “The blood draw experience has long been the Achilles’ heel in the health and wellness market and we believe the Drawbridge solution has the potential to both improve the customer experience and provide health insights to more patients than ever before.” Thorne Research and its subsidiary, WellnessFX, provide health technology platforms for patients in the home. Drawbridge is developing a people-friendly system for collecting and stabilizing blood samples.
You are here: / / Drawbridge Health, Thorne Research announce partnership